Strain Name: |
STOCK Hbatm1Paz Hbbtm1Tow Tg(HBA-HBBs)41Paz/J |
|---|---|
Stock Number: |
003342 |
Availability: | Repository- Live |
General Terms and Conditions |
| Genes & Alleles | HBA1; HBB; HBD; HBG1; HBG2; Hba; Hbatm1Paz; Hbb; Hbbtm1Tow; Tg(HBA-HBBs)41Paz; |
Type JAX® GEMM® Strain - Mutant Stock Additional information on JAX® GEMM® Strains. Type JAX® GEMM® Strain - Targeted Mutation Type JAX® GEMM® Strain - Transgenic Mating System See Colony Maintenance (Female x Male) Species laboratory mouse Donating Investigator Chris Paszty, Amgen, Inc. Generation N1F7G12 (04-DEC-07) Strain Description
This strain was engineered so that it no longer expresses mouse Hba and Hbb, but does express human HBA and HBB. It mimics the genetic, hematologic and histopathologic features that are found in humans afflicted with sickle cell anemia, including irreversibly sickled red blood cells, anemia and multiorgan pathology. A significant percentage of sickle cell mice do not survive to adulthood.Strain Development
A transgenic construct containing human HBA1 (hemoglobin, alpha 1), HBG2 (hemoglobin, gamma G, fetal component), HBG1 (hemoglobin, gamma A, fetal component), HBD (hemoglobin, delta) and HBBS (hemoglobin, beta, sickle allele) genes and the locus control region were injected into fertilized FVB/N mouse eggs. Mice carrying the transgene were bred to mutant mice bearing targeted mutations in the endogenous mouse Hba and Hbb genes. The STOCK background of this strain is a mixture of FVB/N, 129, DBA/2, Black Swiss and >50% C57BL/6 genomes. It was backcrossed to C57BL/6J one generation after importation to The Jackson Laboratory.
Related Disease (OMIM) Terms |
Mammalian Phenotype Terms assigned by genotype |
| Allele Symbol | Hbatm1Paz | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Chris Paszty | ||
| Common Name(s) | Hba0; Hba1-2del; | ||
| Mutation Made By | Chris Paszty, Amgen, Inc. | ||
| Strain of Origin | 129S7/SvEvBrd-Hprt1<+> | ||
| ES Cell Line Name | AB1 | ||
| ES Cell Line Strain | 129S7/SvEvBrd-Hprt1<+> | ||
| Gene Symbol and Name | Hba, hemoglobin alpha chain complex | ||
| Chromosome | 11 | ||
| Molecular Note | Both of the adult hemoglobin genes, alpha 1 and alpha 2, and the region between them were deleted and replaced with a neomycin resistance cassette by homologous recombination. [MGI Ref ID J:28392] | ||
| Allele Symbol | Hbbtm1Tow | ||
| Allele Name | targeted mutation 1, Timothy Townes | ||
| Common Name(s) | Hbb0; Hbbtm1Tmt; | ||
| Mutation Made By | Timothy Townes, University of Alabama School of Medicine | ||
| Strain of Origin | 129S2/SvPas | ||
| ES Cell Line Name | D3 | ||
| ES Cell Line Strain | 129S2/SvPas | ||
| Gene Symbol and Name | Hbb, hemoglobin beta chain complex | ||
| Chromosome | 7 | ||
| Gene Common Name(s) | CD113t-C; HBD; | ||
| General Note | Homozygous mutant animals die in utero. Heterozygous mutant mice are fertile but are anemic and display abnormal red cell morphology, splenomegaly, and markedly increased reticulocyte counts. | ||
| Molecular Note | A genomic fragment encompassing all of Hbb-b1 and a 5' portion of Hbb-b2 was replaced with a neo cassette inserted by homologous recombination. [MGI Ref ID J:29087] | ||
| Allele Symbol | Tg(HBA-HBBs)41Paz | ||
| Allele Name | transgene insertion 41, Chris Paszty | ||
| Common Name(s) | BERK; Tg(Hu-miniLCRalpha1GgammaAgammadeltabetaS); | ||
| Mutation Made By | Chris Paszty, Amgen, Inc. | ||
| Strain of Origin | FVB/N | ||
| Expressed Gene | HBG1, hemoglobin, gamma A, human | ||
| Expressed Gene | HBG2, hemoglobin, gamma G, human | ||
| Expressed Gene | HBA1, hemoglobin, alpha 1, human | ||
| Expressed Gene | HBB, hemoglobin, beta, human | ||
| Expressed Gene | HBD, hemoglobin, delta, human | ||
| General Note | In conjunction with Hbatm1Paz and Hbbtm1Tmt, transgenic mice express exclusively human sickle hemoglobin. These mice do not express mouse Hba and Hbb, but do express human HBA and HBB. Although chronically anemic, most of these mice survive for 2 to 9 months and are fertile. A significant percentage of sickle cell mice do not survive to adulthood. These mice display the major genetic, hematologic and histopathologic features found in humans with sickle cell disease: irreversibly sickled red cells, anemia, and multiorgan pathology. | ||
| Molecular Note | The transgene contains sequences encoding the human proteins HBA1 (hemoglobin, alpha 1), HBG2 (hemoglobin, gamma G, fetal component), HBG1 (hemoglobin, gamma A, fetal component), HBD (hemoglobin, delta), and HBB S (hemoglobin, beta, sickle allele), and the locus control region (LCR). The HBBS allele contains an A to T transversion mutation in the sixth codon of HBB which causes an amino acid change from Glu to Val. The transgene promoter is multiple: from alpha and beta globin humanloci. Transgenic mice express human alpha hemoglobin, gamma hemoglobin, and sickle cell hemoglobin. [MGI Ref ID J:44161] | ||
| Control | ||
|---|---|---|
| 000664 C57BL/6J | (approximate) | |
| Homozygous for Hbatm1Paz, Heterozygous for Hbbtm1Tow, Hemizygous for Tg(HBA-HBBs)41Paz (non-sickling females from the colony) | ||
| Considerations for Choosing Controls | ||
Hbatm1Paz
Hbbtm1Tow
Tg(HBA-HBBs)41Paz
Tg(HBA-HBBs)41Paz QPCR
| Breeding & Husbandry | The Hba and Hbb genes as well as the randomly-inserted transgene are not linked and thus will segregate independently. The breeding strategy utilized by The Jackson Laboratory follows a general scheme of mating non-sickling females with sickling males: Type 1: homozygous for Hbatm1Paz, heterozygous for Hbbtm1Tow, carrying the transgene (-/-, +/-, Tg/?, non-sickling) Approximately 50% of progeny are homozygous for both Hba and Hbb targeted alleles and are hemizygous or homozygous for the transgene (sickling mutant mice). Of the sickling mutant mice, 81% will be hemizygous for the transgene and the other 19% will be homozygous. Only 40% of the sickling mutants will be male. Typically, ~20% of our sickling mutant mice die between weaning and 14 weeks. However, the 80% of mutants that survive beyond 14 weeks do not experience an abnormally high mortality rate. We are currently using trio matings with one male rotating among 4 pens to maximize colony breeding. Mutant females are not suitable for breeding, though we have been successful in transplanting mutant ovaries into immunodeficient recipients (e.g. NOD.CB17-Prkdcscid/J, stock number 001303). Mating female and male mice that are both homozygous for the transgene has not proven to be an effective mating scheme. Undersized litters result and only a small percentage of these are sickling mutant mice. Breeding units supplied to the customer will consist of one female (Type 1) and one male (Type 2). Hemizygosity (Tg/0) or homozygosity (Tg/Tg) of the transgene will be designated when animals are shipped. Due to the small yields of homozygotes and the small average litter size (~5 pups a litter), shipped breeding units may not consist of siblings. Type 2 (sickling) female mice can be obtained individually while Type 2 (sickling) male mutant mice will only be available as part of a breeding unit. Type 1 (non-sickling) females will be available as controls. |
|---|---|
| Diet Information | LabDiet® 5K52/5K67 |
Strains carrying Hbatm1Paz allele
002616 B6.129S7-Hbatm1Paz/J View Strains carrying Hbatm1Paz (1 strain)
Strains carrying other alleles of Hba
001622 B6.CAST-Gpi1a.Cg-Hbath-J 000802 WB.Cg-Hbath-J/J View Strains carrying other alleles of Hba (2 strains)
Strains carrying other alleles of Hbb
000409 B10.129P-H1b Hbbd Tyrc Ea7a/(5M)oSnJ 000418 B10.129P-H1b Tyrc Hbbd/(5M)nSnJ 000432 B10.C-H1b Hbbd Tyrc/(41N)SnJ 000562 B6(Cg)-Tubtub/J 002204 B6.129P2-Hbbtm1Unc/J 000383 B6.C-Tyrc H1b Hbbd/ByJ 002074 B6.Cg-Gpi1a Hbbd H1b/DehJ 003250 B6;129P2-Hbbtm2Unc/J 000899 C.B6-Tyr+ Hbbs/J 000996 C57BL/6J-Hbbd3th/J 000758 C57BL/6J-Hbbp Hrrh-7J/J View Strains carrying other alleles of Hbb (11 strains)
Room Number AX12
Hbatm1Paz relatedHematological Research
Sickle Cell Anemia
Hbbtm1Tow relatedHematological Research
Hemoglobin Defects
Mouse/Human Gene Homologs
thalassemia, alpha
Hematological Research
Hemoglobin Defects
Mouse/Human Gene Homologs
thalassemia, beta
Selected Reference(s)
Additional ReferencesPaszty C; Brion CM; Manci E; Witkowska HE; Stevens ME; Mohandas N; Rubin EM. 1997. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease [see comments] Science 278(5339):876-8. [PubMed: 9346488] [MGI Ref ID J:44161]
| Strain Name: | STOCK Hbatm1Paz Hbbtm1Tow Tg(HBA-HBBs)41Paz/J |
| Stock Number: | 003342 |
IMPORTANT NOTE: Prices are based on shipping destination. To view prices, select your shipping destination.
| Standard Supply | Repository-Live. A collection of over 1000 strains maintained as live colonies. Individual colonies are sized to meet current customer demand. Delivery for orders of 10 mice or less ranges on average from one to eight weeks; mice are generally shipped between four to six weeks of age with a maximum shipping age of ~nine weeks. Colony sizes do not generally support stringent age specifications for large volumes of mice; however custom orders and larger quantities of mice are easily arranged. Estimated ship dates for all orders provided within 48 hours of order placement. |
|---|---|
| Supply Notes |
Usually shipped between four and eight weeks of age. This strain is included in the Induced Mutant Resource Colony collection. Genomic DNA is available for this strain from the Mouse DNA Resource. |
| Licensing | See General Terms and Conditions below for Licensing and Use Restrictions |
| Control Information | View Control Information in Strain Details. |
For additional Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form